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Background: Radiation-induced skin injury is a serious potential complication of ﬂuoroscopically guided interventions.
Transient erythema occurs at doses of 2 to 5 Gy, whereas permanent epilation, ulceration, and desquamation are expected
at doses above this level. Complex endovascular procedures (CEPs), such as fenestrated endovascular aortic aneurysm
repair (FEVAR), are associated with high radiation doses, yet the prevalence of radiation-induced skin injury is unknown.
We hypothesized that skin injury after these exposures is likely to be underrecognized and underreported. This study
examined the frequency and severity of deterministic effects and evaluated patient characteristics that might predispose to
radiation injury in CEP.
Methods: CEP was deﬁned as a procedure with a radiation dose $5 Gy (National Council on Radiation Protection and
Measurements threshold for substantial radiation dose level [SRDL]). Radiation dose and operating factors were
recorded for all CEPs performed in a hybrid room during a 30-month period. Patient medical records were retrospec-
tively reviewed for evidence of skin injury. Patients were seen in follow-up daily until discharge and then at weeks 2 and 6,
months 3 and 6, and 1 year. Phone interviews were conducted to determine the presence of any skin-related complaints.
Peak skin dose (PSD) distributions were calculated for FEVARs with custom software employing input data from
ﬂuoroscopic machine logs. These calculations were validated against Gafchromic ﬁlm (Ashland Inc, Covington, Ky)
measurements. Dose was summed for the subset of patients with multiple procedures within 6 months of the SRDL event,
consistent with Joint Commission recommendations.
Results: Sixty-one CEPs reached a reference air kerma (RAK) of 5 Gy (50 FEVARs, six embolizations, one thoracic
endovascular aortic repair, one endovascular aneurysm repair, one carotid intervention, and two visceral interventions).
The patient cohort was 79% male and had a mean body mass index of 31. The average RAK was 8 6 2 Gy (5.0-15.9 Gy).
Sixteen patients had multiple CEPs within 6 months of the SRDL event, with a mean cumulative RAK of 12 6 3 Gy (7.0-
18.4 Gy). The mean FEVAR PSD was 6.6 6 3.6 Gy (3.7-17.8 Gy), with a mean PSD/RAK ratio of 0.78. Gafchromic
ﬁlm dose measurements were not statistically different from PSD estimations, with a constant of proportionality of 0.99.
Three patients were lost to follow-up before their ﬁrst postoperative visit. No radiation skin injuries were found.
Conclusions: This study represents the largest analysis of deterministic skin injury after CEPs, and our results suggest that
it is less frequent than expected and not increased in CEPs. (J Vasc Surg 2014;60:742-8.)Biologic effects resulting from radiation exposure are
divided into two different types of injury: deterministic
and stochastic. The likelihood of stochastic effects, namely,
cancer formation, increases with the total radiation energy
absorbed by the patient, but the severity of such effects is
independent of dose.1 Deterministic injury, however, is
associated with a threshold radiation dose above which
the severity of injury increases with increasing delivered
dose.2 The most common deterministic effects are skin
and eye injuries, which are infrequent but serious potential
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skin dose that can be observed during a ﬂuoroscopically
guided intervention. The reference air kerma (RAK) is a
measure of the radiation dose to air at a reference point,
which roughly correlates with the patient’s skin and offers
the best estimate of the patient’s skin dose during a proce-
dure.5-7 On interventional ﬂuoroscopes featuring isocentric
gantries, this reference point is called the interventional
reference point and is 15 cm toward the X-ray focal spot
from isocenter (Fig 1).
Although a speciﬁc radiation dose threshold associated
with skin injury has not been determined, the National
Council on Radiation Protection and Measurements
(NCRP) has deﬁned a substantial radiation dose level
(SRDL) to be an RAK equal to or exceeding 5 Gy. This
dose threshold is intended to trigger patient follow-up
directed at detection of skin effects that may require further
management.5 In addition, the Joint Commission’s recog-
nition of skin doses greater than 15 Gy as a reviewable
sentinel event has led to increased awareness of patient
skin injury during ﬂuoroscopically guided interventions.8
Despite increased awareness, the risk of deterministic
skin injury in complex endovascular procedures (CEPs)
has not been examined in large cohort studies. Reports are
mostly limited to case reports after coronary interventions,
Fig 1. Reference air kerma (RAK). IRP, Interventional reference
point.
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systemic shunt procedures.9-13 Fenestrated endovascular
aortic aneurysm repair (FEVAR) has emerged as a valuable
alternative to open aortic repair in certain high-risk pa-
tients; although these cases are consistently high-dose pro-
cedures and often exceed published thresholds for skin
injury, the prevalence of deterministic skin injuries after
FEVAR remains unknown.14 We hypothesized that skin
injury after these exposures is likely to be underrecognized
and underreported. This study sought to examine the fre-
quency and severity of deterministic effects and to evaluate
patient characteristics that might predispose to radiation
injury in CEPs.
METHODS
This study was approved by the UT SouthwesternMed-
ical Center Institutional Review Board. Patient consent was
waived due to the retrospective nature of the study. CEP
was deﬁned as a procedure with a RAK $5 Gy (the
NCRP threshold for SRDL). All patients undergoing ﬂuo-
roscopically guided procedures in an Allura Xper FD20
hybrid room (Phillips Healthcare, Andover, Mass) during
a recent 30-month period were identiﬁed. Radiation dose
and machine operating factors were recorded for eachprocedure. Patient medical records including all outpatient
and inpatient encounters at our institution were retrospec-
tively reviewed speciﬁcally for evidence of skin injury. Pa-
tient comorbidities that might predispose to skin injury
(ie, collagen vascular disorders, hyperthyroidism, diabetes,
ethnicity, and smoking status) were recorded. Patients
were examined daily in the hospital until discharge and
then at 2 weeks, 6 weeks, 3 months, 6 months, and
1 year. To verify the accuracy of clinical notes and to include
any outside hospital evaluations, phone interviews were con-
ducted with all subjects to detect the presence of skin-
related complaints, such as erythema, epilation, or necrosis.
Peak skin dose (PSD) distributions were calculated for
all ﬂuoroscopically guided interventions meeting SRDL
criteria, and a dose index (PSD/RAK ratio)7 was deter-
mined for each case. The calculations were performed
with custom software employing input data from the ﬂuo-
roscope machine logs.14 The machine log data provided
technique factors and system geometry from which a
dose map at the patient’s skin surface was calculated. The
calculations included corrections for machine calibration,
table and support attenuation, and backscatter radiation.
Translational table motion was not provided by the system
logs but was predicted by adjusting the table position to
keep the anatomy of interest in the center of the ﬁeld of
view. To validate the software dose calculations, the simu-
lated dose maps were compared with Gafchromic ﬁlm
(Ashland Inc, Covington, Ky) measurements of ﬁve pa-
tients. Gafchromic ﬁlm was calibrated free in air against
an R100B detector on a Barracuda dosimeter (RTI Elec-
tronics AB, Mölndal, Sweden). The ﬁlm was placed be-
tween the patient and the table pad, centered on the
thoracoabdominal region in the same orientation as used
in the calibrations. Gafchromic ﬁlm densities were
measured with an Epson V700 ﬂatbed scanner (Epson,
Long Beach, Calif) in accordance with published recom-
mendations.15 Film dose measurements were compared
with estimated PSD by linear regression analysis (SPSS Sta-
tistical Package for the Social Sciences). The combined skin
dose effects were investigated for patients who had multiple
ﬂuoroscopically guided interventions in the hybrid oper-
ating room. Consistent with Joint Commission guidelines,
doses from multiple procedures within a 6-month period
were summed. Procedures performed at outside hospitals
or in other subspecialty units were not included.
RESULTS
Of 784 cases performed in a single hybrid operating
room during a 30-month period, 61 exceeded an RAK of
5 Gy, meeting criteria for a CEP. There were 50 FEVARs,
six embolizations, one thoracic endovascular aortic repair,
one endovascular aneurysm repair, one carotid interven-
tion, and two visceral interventions. The patient cohort
was 79% male and had a mean body mass index of 31 6
6. Comorbidities and putative risk factors for skin injury
included smoking (38%), diabetes (28%), predominance
of white, non-Hispanic ethnicity (82%), and systemic lupus
erythematosus (2%) (Table). No instances of other
Table. Patient characteristics
Patient characteristics % (N ¼ 61)
Fair skin 82
Male 79
Smoking 38
Hypertension 95
Coronary artery disease 51
Chronic obstructive pulmonary disease 34
Chronic renal insufﬁciency 30
Diabetes mellitus 28
Systemic lupus erythematosus 2
Fig 2. Reference air kerma (RAK) distribution. CEPs, Complex
endovascular procedures; FEVARs, fenestrated endovascular aortic
aneurysm repairs.
Fig 3. Peak skin dose (PSD) distribution. CEPs, Complex endo-
vascular procedures; FEVARs, fenestrated endovascular aortic
aneurysm repairs.
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collagen vascular disorders, Sjögren syndrome, ataxia-
telangiectasia).
The average RAK for CEPs was 7.7 6 2.1 Gy (range,
5.0-17 Gy) (Fig 2). Sixteen (26%) of the 61 patients had
multiple ﬂuoroscopically guided interventions within
6 months of the SRDL event, with a mean cumulative
RAK of 12 6 3 Gy (range, 7.0-19 Gy). The mean PSD
for all CEPs was 6.8 6 3.3 Gy, and the dose index
(PSD/RAK) was 0.82 6 0.28. The mean FEVAR PSD
was 6.6 6 3.6 Gy (range, 3.7-18 Gy), with a mean
PSD/RAK ratio of 0.78 6 0.26. The average PSD for
the subset of patients with multiple procedures involving
the same irradiated anatomy within 6 months was 9.2 6
3.1 Gy (Fig 3).
Gafchromic ﬁlm dose measurements were not statisti-
cally different from PSD estimations (P < .001). The con-
stant of proportionality from the linear regression was
0.99 6 0.02 (Fig 4). Skin dose maps were characterized
by a concentrated region of radiation with spreading due
to variations in the right anterior oblique/left anterior obli-
que gantry angulation (Fig 5).
Three of the 61 study patients died or were lost to
follow-up before their ﬁrst postoperative visit. All of the
remaining 58 subjects were seen in clinic at 2 or 6 weeks;
43 patients (74%) were seen at either 3 or 6 months, and
45% were seen at 1 year after the SRDL event. No radiation
skin injuries were recorded in any patient, regardless of
PSD. Two patients had skin complaints documented in
the medical record unrelated to radiation: one had a herpes
simplex virus culture-positive focal outbreak of shingles
2 weeks after the procedure; the other had a diffuse
desquamating, erythematous drug reaction.
Of the original 61 subjects in the study, 40 patients
were reached by telephone. Thirteen patients were not
able to be contacted because of incorrect contact informa-
tion or disconnected service, and eight patients were
deceased at the time of phone contact. There was no signif-
icant difference in mean RAK values between the patients
who were contacted and those who were not (P ¼ .6).
There were no skin injuries reported by any of the 40 pa-
tients contacted. One additional patient reported a shingles
outbreak several months after the CEP that improved with
antiviral treatment.DISCUSSION
Case complexity, poor operating practice, and patient
characteristics such as obesity are risk factors for increased
radiation dose delivered during a CEP.2,16 The surgeons
in this study were trained in appropriate operating tech-
niques to limit dose. However, the mean patient body
mass index was obese, and the large majority of cases
were FEVARs, which require a high level of technical detail
and time to complete. Thus, even when best operating
practice is employed, patient factors and case complexity
can lead to high radiation doses. We found this to be
true, as 8% of our cases were considered an SRDL event.
The RAK is the best real-time approximation of PSD;
however, RAK measurements are deﬁned relative to the
X-ray source and not the patient, and therefore RAK
Fig 4. Gafchromic ﬁlm dose vs estimated peak skin dose (PSD).
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angulation. Therefore, combining PSD calculations on
the basis of RAK and machine geometry results in a better
estimate of skin dose compared with RAK alone. The sim-
ilarity between Gafchromic ﬁlm measurements and the
reconstructed dose maps validates our methodology. On
the basis of our calculations, the PSD for a FEVAR was
about 78% of the RAK displayed on the monitor.
Radiation-induced skin lesions can be loosely classiﬁed
as prompt (0-2 weeks), early (2-8 weeks), midterm
(6-52 weeks), and late (>40 weeks), depending on the
timing after exposure. In addition, the radiation response
is dose dependent, and the National Cancer Institute has
deﬁned four grades of skin toxicity for radiation dermatitis.
The most frequently reported prompt reaction is transient
erythema (grade 1), which is an inﬂammatory-type reaction
with changes in cellular permeability and histamine
release.12 This can occur at skin doses as low as 2 Gy.5,17
Early reactions include temporary epilation, the main
erythematous reaction, and moderate tissue edema (grade
2), which can occur at skin doses of 3 to 6 Gy. The induc-
tion of more severe effects, such as dry or moist desquama-
tion (grade 3), is related to cellular loss and occurs at PSDs
greater than 10 Gy.5 Midterm reactions can include dermal
atrophy, necrosis, and ulceration (grade 4), which can be
seen at PSDs >15 Gy. Long-term reactions can be mani-
fested as telangiectasia, further dermal thinning, and deeper
ulceration.12 On the basis of the distribution of calculated
PSDs, we would expect to have found grade 1 to grade 3
effects. The follow-up in this study was rigorous enough
and at the appropriate interval that both minor and major
injury should have been detected.
Despite these published guidelines for radiation injury
thresholds, the actual radiation dose required to cause
deterministic skin injury is patient speciﬁc and can vary
widely on the basis of individual biologic variation in radi-
ation sensitivity and the presence or absence of certain
coexisting conditions.1 The incidence of radiation-
induced skin injury is thought to be less than 0.01% of ﬂuo-
roscopically guided interventions; however, it is likely tobe underreported, underrecognized, or misdiagnosed.13
Combining cases in the literature before 2001, Koenig
et al4 reported on 73 cases of skin injuries from endovascu-
lar procedures including percutaneous coronary inter-
ventions, transjugular intrahepatic portosystemic shunt
procedures, and neuroembolizations. Approximately half
of these cases resulted in ulceration, and 25% required
skin grafting. Since that time, skin injury reports have
appeared sporadically in the literature.13,18 One recent
report evaluated 400 percutaneous coronary interventions
and found six patients with mild erythema that was dis-
played within 4 weeks after the procedure. The minimal
skin dose for injury was 6 Gy.19 In the present study, the
mean PSD was greater than this, yet no skin injuries were
observed. This suggests that other variables may predispose
to skin injury.
Certain patient factors are believed to modify the
normal response of skin to radiation and thus predispose
patients to injury after a CEP. Collagen vascular disease,
particularly scleroderma, systemic lupus erythematosus,
and mixed connective tissue disease, has been associated
with increased susceptibility to skin injury at lower
doses.10,20 The one patient in the present study with sys-
temic lupus erythematosus received a PSD of 8.5 Gy
without adverse skin sequelae. Diabetes mellitus, current
smoking status, and fair skin have also been reported to
promote an accelerated and increased skin reaction after ra-
diation exposures.9,12,21,22 Almost 30% of our cohort was
diabetic, with an even greater percentage of current
smokers and fair-skinned individuals with no observed
skin injuries. This suggests that risk factors for skin injury
may be more complex than previously reported. No other
risk factors for skin injury were present in the cohort, such
as hyperthyroidism or defects in DNA repair genes (ataxia-
telangiectasia, xeroderma pigmentosum) or the current
application of chemotherapeutic agents.3,9,21 Therefore,
these additionally cited risk factors could not be evaluated.
Likewise, we did not assess other risk factors, such as poor
nutritional status or compromised preoperative skin
integrity.23
Previous radiation doses to the same area of skin that
will be irradiated for the planned CEP can increase the
risk of deterministic effects, depending on the radiation
dose of each procedure and the time interval between
them.12 The Joint Commission recommends that doses
from previous procedures to the same body area be
summed during a 6- to 12-month period. Because the bio-
logic repair process in the skin is complete at approximately
2 months, we used a 6-month period as our time frame in
accordance with the NCRP clinical recommendation.5,12,24
No skin injury was observed in the patient subset with mul-
tiple procedures. Summing PSD for multiple procedures
will overestimate the potential for skin injury because it
does not consider skin recovery and regeneration. There-
fore, the risk factor of multiple ﬂuoroscopically guided in-
terventions for skin injury is complex and requires more
rigorous consideration of time between procedures. None-
theless, this suggests that multiple procedures within a
Fig 5. a,Gafchromicﬁlmpeak skindose (PSD)map.b,PSDestimation for the samecomplexendovascular procedure (CEP).
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as previously considered.
Several study limitations must be acknowledged. First,
the retrospective nature of this study makes it possible that
minor skin injuries (grade 1) went unrecognized. Whereas
we assumed that a full physical examination was conducted
of each patient’s back during follow-up, thorough back
examinations may not have been universally performed.
Furthermore, it was not our previous practice to ask pa-
tients about skin complaints during follow-up. Phone inter-
views were conducted to supplement the medical record;
however, these interviews were subject to recall bias. None-
theless, the expected number of grade 2 or grade 3 injuries
should have been detected.
A few patients died before their ﬁrst postoperative visit
and only 65% were reached for a phone interview, and
therefore it is possible that some injuries went unreported;
however, the radiation doses for patients who were lost to
follow-up were not statistically different from those of pa-
tients who were contacted. Therefore, similar injuries
would be expected between the two groups. Further pro-
spective analysis is clearly needed to quantify the risk of
skin injury in patients undergoing CEP.
Another limitation is that not all patients in this study
were examined at the designated time intervals after the
original CEP. Although all patients were examined at 2
or 6 weeks, which is thought to be the best time frame
to detect minor skin injuries, many of the patients were
from out of state and had follow-up at other institutions af-
ter their ﬁrst or second postoperative visit. It is possible that
late effects may have occurred in some patients after this
time. Nevertheless, the data are novel in demonstrating
that deterministic skin injuries do not necessarily occur at
high radiation doses.
A third limitation is that the number of patients in this
study was relatively small, and the diversity of the study
cohort was limited. The majority of subjects were white
men; therefore, the results may not be applicable to women
or to individuals of other backgrounds. Furthermore, there
was a relative paucity of putative risk factors for deterministic
skin injury, such as systemic lupus erythematosus. We
acknowledge the possibility that a larger and more varied pa-
tient population may have demonstrated some deterministiceffects. Nevertheless, the present study of consecutive pa-
tients from a single institution represents the largest analysis
of deterministic skin injury after CEP, and our results sug-
gest that serious injuries are less prevalent than the published
dose thresholds would predict. A large number of subjects
will be needed to determine the prevalence of skin injury
after CEP, which will best be accomplished in a multi-
institutional study.
CONCLUSIONS
The International Commission on Radiological Protec-
tion has recommended that patients be counseled on radi-
ation risks before a CEP. Despite the fact that radiation is
discussed in the consent process for FEVARs, many of
the patients contacted by telephone did not know that ra-
diation exposure was involved in their procedure, and this
may have contributed to minor injuries going unrecog-
nized. To correct this, our practice has implemented new
procedures directed at recognizing skin injury in accor-
dance with NCRP guidelines after SRDL events.5 FEVAR
patients are questioned at each follow-up visit about any
skin-related complaints, and a full skin examination is per-
formed. With this new policy in place, we may discover that
skin injury is occurring. Nonetheless, it appears that deter-
ministic effects are less frequent than previously reported
and not increased in CEPs.
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Submitted Jan 21, 2014; accepted Mar 10, 2014.DISCUSSIONDr Christopher G. Carsten, III (Greenville, SC). In the cur-
rent study, Dr Kirkwood and colleagues have updated their data-
base on the radiation exposure of patients undergoing complex
endovascular procedures and examined the frequency and severity
of skin injuries associated with exposure to greater than 5 Gy of ra-
diation using reference air kerma (RAK) to determine the radiation
dose level. Peak skin doses (PSDs) were calculated with custom
software from ﬂuoroscopic machine logs and correlated to Gaf-
chromic ﬁlm exposures. Skin injuries were detected by retrospec-
tive chart review and phone interviews of patients.
Transient skin erythema has been previously reported with
doses starting at 2 Gy. In this study, the average RAK was
7.7 Gy, and the mean calculated PSD was 6.8 Gy. Notably, 15%
of patients in this series received greater than 10 Gy of PSDs; how-
ever, no patient in this series was identiﬁed as having even grade 1
skin injury, leading the authors to conclude that perhaps the deter-
ministic effects of radiation exposure are somehow lower in our
patients than in previously reported series.
I have several questions for the authors.
In reviewing your manuscript this year and comparing it with
the manuscript presented at this meeting last year, I noted that at
your institution an educational event was undertaken to educate
surgeons on radiation safety after it was noted that there were a
number of procedures with patient exposures of more than
6 Gy. No mention is made in the current manuscript of the chro-
nologic distribution of patient exposures. Did the higher exposures
occur earlier in the series when there was less radiation awareness
and thus less attention at follow-up examinations to possible
injuries?
In the same vein of thought, this study relies on retrospective
chart review to detect the presence of a red rash or ulcer found ona vascular patient’s back. In the manuscript, you qualify that it was
assumed that a full physical examination was conducted at each of
the patient’s follow-up visits. I do not know about at your institu-
tion, but many vascular notes that I read tend to focus on the front
of patients with scant mention of their skin or back. Could you
comment on the number of charts that contained speciﬁc docu-
mentation of either a skin or back examination?
Finally, given vascular surgery’s lackluster history of radiation
safety awareness and compliance, is the apparent message that our
procedures are somehow less likely to cause skin injury to our pa-
tients compared with prior reports by other specialties the appro-
priate message that we wish to convey?
I applaud your efforts to continue to draw the attention of our
specialty to an area of our practice that has been ignored for too
long.
Dr Melissa L. Kirkwood. Thank you, Dr Carsten, those are
wonderful questions that address important points. To address
the ﬁrst question, yes, we did present a manuscript last year on
how surgeon education in the appropriate use of operating fac-
tors can lower PSD. If you look at the case distribution of the
cases that reached 5 Gy RAK before and after the surgeon educa-
tional event, you see that the outlier cases, visceral interventions,
standard endovascular aneurysm repairs, and thoracic endovascu-
lar aortic repairs, were only in the pre-education group. After sur-
geon education, only fenestrated endovascular abdominal
aneurysm repair (FEVARs) continuously required high radiation
doses. This suggests that we are using appropriate technique to
limit dose; however, case complexity is a main contributor to
increased radiation exposure.
To address the second question, there are several limitations
to this study, and you point out the biggest one. It was a
JOURNAL OF VASCULAR SURGERY
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of the back was performed in the clinic at each visit, and that may
not have always been done. That is why we relied heavily on the
telephone interviews, in which we directly asked patients about
any history of skin-related complaints after their complex endovas-
cular procedure. I also looked at all medical notes to see whether
each patient had any dermatology visits or primary care appoint-
ments for skin complaints. Two patients were seen by a dermatol-
ogist, one had a culture-positive herpes outbreak, and another
suffered a diffuse desquamating skin reaction secondary to an anti-
biotic. The possibility of inadequate skin examinations during
follow-up is a weakness of the study because some minor grade
1 or grade 2 injuries could have been missed. That is why during
the last 6 months we have changed our routine to ensure that all
FEVAR patients are questioned about skin erythema, ulceration,desquamation, and necrosis and that each patient has a full skin
examination.
In terms of the third question, no, I do not believe that our
patient population is any different from, for example, the patients
who developed radiation-induced skin injury in the coronary liter-
ature. However, as demonstrated by the PSD maps from FEVARs,
there is a great amount of gantry angulation in these cases that
tends to spread skin dose much more than perhaps a coronary
intervention, in which the radiation is limited to a smaller area.
This dose spreading decreases the PSD to any one area and thus
decreases the potential for injury. This study highlights that
conventionally considered risk factors for skin injury are not clear
and we do not know who is most susceptible. Therefore, more
prospective data are needed to be able to properly identify patients
at risk for radiation-induced skin injury.
